Stuart A. Arbuckle
2016
In 2016, Stuart A. Arbuckle earned a total compensation of $5.6M as EVP & Chief Commercial Officer at Vertex Pharmaceuticals, a 37% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $420,000 |
|---|---|
| Option Awards | $1,305,144 |
| Salary | $672,885 |
| Stock Awards | $3,150,148 |
| Other | $12,885 |
| Total | $5,561,062 |
Arbuckle received $3.2M in stock awards, accounting for 57% of the total pay in 2016.
Arbuckle also received $420K in non-equity incentive plan, $1.3M in option awards, $672.9K in salary and $12.9K in other compensation.
Rankings
In 2016, Stuart A. Arbuckle's compensation ranked 1,364th out of 14,075 executives tracked by ExecPay. In other words, Arbuckle earned more than 90.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,364 out of 14,075 | 90th |
Division Manufacturing | 458 out of 5,488 | 92nd |
Major group Chemicals And Allied Products | 124 out of 1,900 | 94th |
Industry group Drugs | 84 out of 1,543 | 95th |
Industry Pharmaceutical Preparations | 68 out of 1,173 | 94th |
Source: SEC filing on April 28, 2017.
Arbuckle's colleagues
We found five more compensation records of executives who worked with Stuart A. Arbuckle at Vertex Pharmaceuticals in 2016.
2016
Jeffrey Leiden
Vertex Pharmaceuticals
Chief Executive Officer
2016
Michael Parini
Vertex Pharmaceuticals
EVP & Chief Legal and Administrative Officer
2016
Ian Smith
Vertex Pharmaceuticals
Chief Financial Officer
2016
Amit Sachdev
Vertex Pharmaceuticals
EVP & Chief Regulatory Officer
2016
David Altshuler
Vertex Pharmaceuticals